Drugs / AbGn168
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00848055 | Dec 2008 → Oct 2010 | psoriasis | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AbGn168 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00848055 ↗ |
| Route | Intravenous | “single dose intravenous infusion” NCT00848055 ↗ |